Cardiovascular clinical trials market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). Pivotal factors including the increasing prevalence of peripheral vascular diseases (PVDs) and coronary artery diseases (CAD). According to the World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. In addition, an academic clinical research organization united the clinical expertise and academic leadership of a premier teaching hospital with the capabilities of a full-service contract research organization. The research teams of faculty and operational experts are providing independence, scientific leadership, and collaborative approaches to look at research challenges differently. For instance, in June 2023, Duke Clinical Research Institute entered a new partnership with Novo Nordisk to fight cardiovascular disease. This partnership is driven by a motivation to produce first-in-class therapies capable of meeting the patients’ urgent medical needs.
Get Free Sample link @ https://www.omrglobal.com/request-sample/cardiovascular-clinical-trials-market
The global cardiovascular clinical trials market is segmented on the product, mode of delivery and end-user. Based on the phase, the market is sub-segmented into phase i, phase ii, phase iii, phase iv. Based on the study design, the market is sub-segmented into observational, interventional, and expanded access. Further, based on Indication, the market is sub-segmented into coronary artery disease, acute coronary syndrome, pulmonary arterial hypertension, ischemic heart disease, stroke, heart failure, and others. Where, the other indication includes cardiac arrhythmias. Among the study design, the interventional sub-segment is anticipated to hold a considerable share of the market, owing to the minimizing the effect of confounding, and avoid bias in allocation to exposure groups.
full report of Cardiovascular Clinical Trials Market available @ https://www.omrglobal.com/industry-reports/cardiovascular-clinical-trials-market
- Market Coverage
- Market number available for – 2023-2029
- Base year- 2022
- Forecast period- 2023-2029
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
- , and others
Market Segmentation
Global Cardiovascular Clinical Trials Market by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Global Cardiovascular Clinical Trials Market by Study Design
- Observational
- Interventional
- Expanded Access
Global Cardiovascular Clinical Trials Market by Indication
- Coronary Artery Disease
- Acute Coronary Syndrome
- Pulmonary Arterial Hypertension
- Ischemic Heart Disease
- Stroke
- Heart Failure
- Others (Cardiac Arrhythmias)
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Caidya
- Cardialysis B.V.,
- Cardiovascular Clinical Science Foundation
- Clearwater Cardiovascular Consultants
- Cytokinetics, Inc.
- Eli Lilly and Co.
- HonorHealth
- Inova Health System
- MCRA, LLC
- PPD Inc. (Thermo Fisher Scientific Inc.
- SGS SA
- Syneos Health
- Veeda Clinical Research Ltd.
- Vial Health Technology, Inc.
- Worldwide Clinical Trials
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global cardiovascular clinical trials market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cardiovascular-clinical-trials-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
